Results 271 to 280 of about 2,442,464 (298)

Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings

Ca-A Cancer Journal for Clinicians, 2006
M A McDiarmid, Thomas H Connor
exaly  

Outcome of Combining Epigenetic Drugs With Other Treatments in the Clinic

Medical Epigenetics, 2016
Paromita Raha
exaly  

Food and Drug Administration, Partner in Drug Development

Ca-A Cancer Journal for Clinicians, 2006
Jérôme W Yates, J W Yates
exaly  

Development of the Generic Drug Industry in the US After the Hatch-Waxman Act of 1984

Acta Pharmaceutica Sinica B, 2013
Liang Han, Qiang Zheng
exaly  

Prices of Generic Drugs Associated With Numbers of Manufacturers

New England Journal of Medicine, 2017
Chintan V Dave, Abraham G Hartzema
exaly  

High-Cost Generic Drugs — Implications for Patients and Policymakers

New England Journal of Medicine, 2014
Jonathan D Alpern
exaly  

Patients’ Attitudes Towards Generic Drug Substitution in Japan

Health Policy, 2011
Eriko Kobayashi, Tomoya Sakurada, Nobunori Satoh   +2 more
exaly  

Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending

Milbank Quarterly, 2017
Olivier J Wouters
exaly  

Generic drugs.

The Medical letter on drugs and therapeutics, 1986
openaire   +3 more sources

The Ongoing Regulation of Generic Drugs

New England Journal of Medicine, 2007
Richard G. Frank
exaly